The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Target Advancement Program, 2016Characterization of TNIK as a LRRK2 Kinase
Study Rationale:
The LRRK2 protein undergoes chemical modification called phosphorylation, which can alter its function, and is carried out by enzymes called kinases (LRRK2 is also a kinase)... -
Target Advancement Program, 2016High-throughput LRRK2 Ubiquitination Assay
Study Rationale:
The LRRK2 protein is regulated by modifications called phosphorylation, which occurs at several specific sites on the protein (Serines910, 935, 955, 973) and can alter the biology of... -
Biomarkers Across Neurodegenerative Diseases, 2016Network Models of Neurodegeneration (NetMON)
Study Rationale:
The global aging population has placed neurodegenerative diseases, such as Parkinson’s and Alzheimer’s, among the biggest public health challenges of 21st century healthcare. It is...
-
Research Grant, 2016Impact of LRRK2 Kinase Activity on Synaptic Vesicle Trafficking
Promising Outcomes of Original Grant:
Our previous work provided evidence that LRRK2 plays a crucial role in neurons by affecting the trafficking (movement across the cell) of synaptic vesicles... -
Research Grant, 2016LRRK2 Safety Initiative
Study Rationale:
Previous pre-clinical work with Genentech, Inc. has demonstrated that LRRK2 kinase inhibitors may induce abnormal findings in the lungs. This study will determine if this result is due... -
Research Grant, 2016SudoScan as a Biomarker of Parkinson's Disease
Study Rationale:
Currently, there is no single test that can be used to confirm a diagnosis of Parkinson's disease (PD) or a biomarker that can track its progression. People with PD have many...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.